Uzbekistan Recognition Pathway: Proving the Identical Configuration Requirement
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The core of a recognition-pathway submission is a declaration of identical configuration: confirmation that the device placed on the Uzbekistan market is fully identical to the device covered by the reference approval in model, specification, manufacturing site, and intended purpose. This element is the most frequent source of problems in recognition-pathway applications, because any single deviation from the reference approval, whether a different model number, a different sterilization method, or a different software version, triggers a full review or an outright refusal. What the recognition pathway exempts is the work of generating evidence; it does not exempt the work of proving consistency. Manufacturers should therefore treat the configuration comparison as a formal deliverable with sign-off, not as an assumption carried over from the foreign approval, and should resolve every known deviation before submission rather than explaining it after a deficiency notice arrives.
The comparison work also has a documentation dimension. The foreign approval, the Uzbekistan dossier, the labeling, and the certificates that support the submission must all describe the same device in the same terms, and the coding entries under registered order No. 3888 give reviewers a quick technical check of that alignment. A manufacturer who reconciles these documents before submission turns the recognition application into a confirmation exercise; a manufacturer who discovers the differences after submission turns it into a deficiency negotiation, with the review clock suspended while the explanation travels back and forth. In both cases the underlying device is the same, but the project outcomes differ sharply, which is why the comparison table should be treated as a controlled deliverable with named owners and dates.
2. Legal basis
| Regulation | Reference number | Date | Provisions |
|---|---|---|---|
| Cabinet of Ministers Resolution approving the Regulation on State Registration of Medicinal Products and Medical Devices and the Issuance of Registration Certificates | No. 738 | Adopted November 24, 2025; effective February 26, 2026 | Conditions for applying the recognition pathway and the consistency requirements |
| Cabinet of Ministers Resolution approving the Regulation on State Registration of Medicinal Products and Medical Devices and the Issuance of Registration Certificates | No. 738 | Adopted November 24, 2025 | Item 2.1: device information, including field of application, a brief description, models, the device and its components, a description of the parts, together with GMDN and UDI codes |
| Registered rule on compiling registration dossiers for medical devices (registered order) | No. 3888 | Registered July 2026; effective October 8, 2026 | A single device must be declared with one unique GMDN code and one unique UDI code |
| Cabinet of Ministers Resolution approving the Regulation on State Registration of Medicinal Products and Medical Devices and the Issuance of Registration Certificates | No. 738 | Adopted November 24, 2025; effective February 26, 2026 | Where the labeling, intended purpose, or manufacturing circumstances differ from the reference dossier, or Uzbekistan-specific requirements (language, electrical standards, sterile claims) are not met, the center retains the right to refuse |
3. Expert insights
Insight one: identical configuration means four-dimensional consistency, not the same product name. Model, specification, manufacturing site, and intended purpose are all required, and none can be missing. When GRZAN reviews a recognition-pathway application, the reference approval documents and the Uzbekistan submission are compared cell by cell in a structured table, rather than checking whether the product names match.
Insight two: software versions and sterilization methods are the two most commonly overlooked variables. Once the firmware version of an active device is updated, its configuration already differs from the configuration covered by the reference approval; likewise, changing the sterilization method or the sterilization supplier of a sterile device constitutes a configuration change. Inside companies these are often treated as minor changes that do not affect the main model, but in the comparison logic of the recognition pathway they are substantive differences.
Insight three: the unique coding requirements provide a practical tool for the consistency comparison. Registered order No. 3888 requires each device to be declared with a unique GMDN code and a unique UDI code. These two codes can serve as technical anchors when comparing the reference approval with the submitted configuration: if the codes differ, additional written explanation of the configuration consistency will be needed.
Insight four: Uzbekistan-specific requirements can override consistency. Even with an identical configuration, the center may still refuse if the labeling, intended purpose, or manufacturing circumstances differ from the reference dossier, or if local requirements on language, electrical standards, and sterile claims are not met. Consistency is therefore a necessary condition, not a sufficient one, and localization compliance remains a separate gate that must be cleared on its own.
4. Practical recommendations
- Build a four-column comparison table of the reference approval versus the Uzbekistan submission (model, specification, manufacturing site, intended purpose) and obtain sign-off for each cell.
- Include software versions and sterilization methods in the comparison table and manage them alongside the model number.
- Use the GMDN and UDI codes as auxiliary tools for the consistency comparison, and prepare a written explanation whenever the codes differ.
- Before submitting a recognition-pathway application, complete the localization check covering language, electrical standards, and sterile claims.
- Provide verified copies of the reference approval documents and retain records of verification through public channels.
5. Verification checklist
- □ The four-column comparison table (model, specification, manufacturing site, intended purpose) is complete and confirmed cell by cell
- □ Software versions and sterilization methods are included in the comparison table
- □ The unique GMDN code and the unique UDI code have been declared
- □ Labeling, instructions for use, and packaging have passed the localization check (language, electrical standards, sterile claims)
- □ The reference approval documents are verified copies, with verification records retained
- □ It is confirmed that consistency is a necessary condition and not a sufficient one
GRZAN provides registration support in Uzbekistan for manufacturers, importers, and authorized representatives, including configuration comparison against reference approvals. For assistance, contact info@grzanglobal.com.
Regulatory information verified as of October 29, 2026.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us